ROMAN HAILU: Open Payments
NPI 1538413794 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,766 in 175 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $147 · 2025 $3,766
Food & beverage: $3,583Education: $183
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $1,075 |
| Janssen Biotech, Inc. | 20 | $601 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $350 |
| PFIZER INC. | 12 | $272 |
| Lilly USA, LLC | 12 | $236 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $192 |
| GENZYME CORPORATION | 7 | $188 |
| Aimmune Therapeutics, Inc. | 12 | $184 |
| Madrigal Pharmaceuticals | 7 | $150 |
| Phathom Pharmaceuticals, Inc. | 6 | $100 |
Products named: TREMFYA, RINVOQ, SKYRIZI, ENTYVIO, OMVOH, DUPIXENT, VELSIPITY, XIFAXAN.
Industry payments across MO — which companies pay providers there.
